Literature DB >> 31682847

The therapeutic effect of dexmedetomidine on protection from renal failure via inhibiting KDM5A in lipopolysaccharide-induced sepsis of mice.

Yan Liu1, Yanming Yu2, Jicheng Zhang3, Chunting Wang4.   

Abstract

BACKGROUND: Sepsis is an inflammatory response undergoing the complicate pathophysiological changes for host defense against pathogens. Previous studies suggested that dexmedetomidine (DEX) was served to controlling the over-reactive inflammatory effects to protect from the sepsis-induced organ failure via modulating histone methylation. However, the genome-wide changes of histone methylations upon DEX for sepsis treatment were poorly explored.
MATERIALS AND METHODS: The acute kidney injury (AKI) mouse model were induced by lipopolysaccharide (LPS). DEX and KDM5 (H3K4 demethylases) inhibitors were used to add additionally. H3K4me3 antibody was used to conduct the ChIP-seq assay in renal cortex tissues.
RESULTS: We observed that the overall H3K4me3 levels were obviously declined in AKI group compared to the normal control. We further observed that the therapeutic effect of DEX was basically equal with CPI-455 and KDM5A-IN-1 but better than PBIT. The overall H3K4me3 level was reduced in AKI group compared to DEX (p = 0.008), and KDM5A-IN-1 groups (p = 0.022). The H3K4me3 enrichment of the multiple genes associated with inflammatory cytokines such as TNF-α, NOS2 and CCL2 increased in AKI model, but decreased upon DEX or KDM5A-IN-1 treatment. Consistently, transcription and protein levels of genes such as TLR4, MYD88, MTA1, PTGS2, CASP3 associated with NF-κB signaling pathway were all compromising after treated with DEX or KDM5A-IN-1 groups compared to AKI group.
CONCLUSION: Taken together, our data determined that DEX could attenuate AKI through KDM5A inhibition in sepsis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DEX; H3K4me3; KDM5A; Renal failure; Sepsis

Mesh:

Substances:

Year:  2019        PMID: 31682847     DOI: 10.1016/j.lfs.2019.116868

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Dexmedetomidine reverses MTX-induced neurotoxicity and inflammation in hippocampal HT22 cell lines via NCOA4-mediated ferritinophagy.

Authors:  Jingli Chen; Juan Wang; Chenxi Li; Huang Ding; Jishi Ye; Zhongyuan Xia
Journal:  Aging (Albany NY)       Date:  2021-02-25       Impact factor: 5.682

Review 2.  The emerging role of KDM5A in human cancer.

Authors:  Guan-Jun Yang; Ming-Hui Zhu; Xin-Jiang Lu; Yan-Jun Liu; Jian-Fei Lu; Chung-Hang Leung; Dik-Lung Ma; Jiong Chen
Journal:  J Hematol Oncol       Date:  2021-02-17       Impact factor: 17.388

3.  Effects of intravenous lidocaine, dexmedetomidine, and their combination on IL-1, IL-6 and TNF-α in patients undergoing laparoscopic hysterectomy: a prospective, randomized controlled trial.

Authors:  Siqi Xu; Shenghong Hu; Xia Ju; Yuanhai Li; Qing Li; Shengbin Wang
Journal:  BMC Anesthesiol       Date:  2021-01-06       Impact factor: 2.217

4.  Coordination of PRKCA/PRKCA-AS1 interplay facilitates DNA methyltransferase 1 recruitment on DNA methylation to affect protein kinase C alpha transcription in mitral valve of rheumatic heart disease.

Authors:  Zan Xie; Qianli Wang; Shaojuan Hu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  Epigenetic modification mechanism of histone demethylase KDM1A in regulating cardiomyocyte apoptosis after myocardial ischemia-reperfusion injury.

Authors:  Lin He; Yanbo Wang; Jin Luo
Journal:  PeerJ       Date:  2022-08-05       Impact factor: 3.061

Review 6.  JMJD family proteins in cancer and inflammation.

Authors:  Wang Manni; Xue Jianxin; Hong Weiqi; Chen Siyuan; Shi Huashan
Journal:  Signal Transduct Target Ther       Date:  2022-09-01

Review 7.  The Role of Histone H3 Methylation in Acute Kidney Injury.

Authors:  Yi-Bo Zhao; Wei Wei; Xiao-Xi Lin; Yan-Fen Chai; Heng Jin
Journal:  Drug Des Devel Ther       Date:  2022-08-02       Impact factor: 4.319

8.  Urinary EGF and MCP-1 and risk of CKD after cardiac surgery.

Authors:  Steven Menez; Wenjun Ju; Rajasree Menon; Dennis G Moledina; Heather Thiessen Philbrook; Eric McArthur; Yaqi Jia; Wassim Obeid; Sherry G Mansour; Jay L Koyner; Michael G Shlipak; Steven G Coca; Amit X Garg; Andrew S Bomback; John A Kellum; Matthias Kretzler; Chirag R Parikh
Journal:  JCI Insight       Date:  2021-06-08

9.  Dexmedetomidine Alleviates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting p75NTR-Mediated Oxidative Stress and Apoptosis.

Authors:  Zhe Wang; Jiali Wu; Zhaolan Hu; Cong Luo; Pengfei Wang; Yanling Zhang; Hui Li
Journal:  Oxid Med Cell Longev       Date:  2020-10-31       Impact factor: 6.543

10.  2,4,6-Trihydroxy-3-geranyl acetophenone suppresses vascular leakage and leukocyte infiltration in lipopolysaccharide-induced endotoxemic mice.

Authors:  Yee Han Chan; Nazmi Firdaus Musa; Yi Joong Chong; Siti Arfah Saat; Faizul Hafiz; Khozirah Shaari; Daud Ahmad Israf; Chau Ling Tham
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.